Case Reports

​

Every UPC, EPO and national court decision our fee earners have written up — now filterable by the same 40+ tags they already use to classify each report, plus the court and industry sector behind it.

Tags
No tags match that search.
Court
No courts match that search.
Sector
No sectors match that search.
0 of 100
Case Reports
Tag
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
​
Tag
:
Tag

Registered Community Designs: reasons for refusal

19 April 2012
2012-04-19

The OHIM has begun publishing information about Registered Community Design applications that have been refused.The designs themselves are not shown, but the grounds for refusal are now being made...

#
Building a Resilient Quantum Patent Portfolio: Winning the Race to File First
No items found.
No items found.
​

Sanofi-Aventis patents on cancer drug Taxotere declared invalid

11 April 2012
2012-04-11

Two Sanofi-Aventis US patents for the cancer drug docetaxel, marketed as Taxotere, have been declared invalid by the Court of Appeals for the Federal Circuit.

#
Litigation
#
Life
No items found.
No items found.
​

Samsung v Apple tablet battle hits the UK

05 April 2012
2012-04-05

The ongoing dispute between Apple and Samsung over Apple's Registered Community Designs for its iPad has now entered the UK courts.Darren Smyth's latest IPKat post relates to a decision of Mr Justice...

#
Digital
#
Building a Resilient Quantum Patent Portfolio: Winning the Race to File First
No items found.
No items found.
​

Poland's law on cheap drugs declared contrary to EU law

03 April 2012
2012-04-03

A Polish law which allowed the sale of unapproved drugs which were cheaper than those approved has been declared contrary to EU law.The decision by the Court of Justice of the European Union is...

#
Life
No items found.
No items found.
​

Regeneron Pharmaceuticals Inc, Bayer Pharma AG v Genentech Inc

29 March 2012
2012-03-29

In today's IPKat, Darren Smyth analyses the decision in Regeneron Pharmaceuticals Inc, Bayer Pharma AG v Genentech Inc, a case which started as an action for a declaration of invalidity of...

#
Life
No items found.
No items found.
​

AstraZeneca patent revoked for obviousness

29 March 2012
2012-03-29

In a decision on 22 March in Teva and ors v AstraZeneca concerning a patent on a sustained release formulation of an anti-psychotic drug, Mr Justice Arnold revoked the patent due to obviousness.

#
Life
No items found.
No items found.
​

UK Government confirms Patent Box scheme

27 March 2012
2012-03-27

Chancellor George Osborne confirmed in his 2012 Budget that the proposed Patent Box scheme will go ahead.When fully phased in, the rate of Corporation Tax on profits attributed to patents will be 10%.

#
Life
#
Patent Strategy
No items found.
No items found.
​

EPO publishes draft version of revised Guidelines for Examination 2012

26 March 2012
2012-03-26

The European Patent Office (EPO) has published the draft version of revised Guidelines for Examination 2012 online.Partner Darren Smyth casts his eye over the draft version in his latest IPKat post.

#
Elements
No items found.
No items found.
​

Compulsory licensing in India – Must products be manufactured locally?

16 March 2012
2012-03-16

The first compulsory licence of an Indian patent since the TRIPS regime was implemented in India has been awarded. Although the licence relates to a pharmaceutical product, the grounds on which the...

#
Life
#
Patent Strategy
No items found.
No items found.
​

TRIPS and compulsory licensing

15 March 2012
2012-03-15

Following on from his IPKat post about India granting its first compulsory licence, Darren Smyth explores what limitations the TRIPS agreement puts on compulsory licensing in his latest blog.

#
Life
No items found.
No items found.
​

India grants first compulsory licence

14 March 2012
2012-03-14

The first compulsory licence has been granted by the Controller of Patents Mumbai.The application concerns the anti-cancer drug Sorafenib, a patented drug owned by Bayer Corporation.

#
Life
No items found.
No items found.
​

Scientific publishing: learned society journals v commercial alternatives

09 March 2012
2012-03-09

The subject of today's IPKat post - The Cost of Knowledge - by Darren Smyth concerns a campaign against Elsevier, the publisher of academic journals.

#
Elements
No items found.
No items found.
​

EPO Boards of Appeal: recent decisions

05 March 2012
2012-03-05

Recent decisions of the Boards of Appeal of the EPO are now updated continuously on the EPO website.In today's IPKat blog, Darren Smyth highlights some noteworthy cases from the first two months of...

#
Elements
No items found.
No items found.
​

Owning Community registered design provides no protection from infringement proceedings

02 March 2012
2012-03-02

SummaryThe Court of Justice of the European Union (CJEU) has confirmed that owning a Community registered design (CRD) does not provide a defence to an infringement action relating to earlier CRDs.

#
Building a Resilient Quantum Patent Portfolio: Winning the Race to File First
No items found.
No items found.
​

EPO and Google launch patent translation service

29 February 2012
2012-02-29

The European Patent Office (EPO) has launched a new patent translation service which uses Google's Translate technology.Reported by partner Darren Smyth via his IPKat blog, the service initially...

#
Elements
No items found.
No items found.
​
No results found.
Please try updating your search criteria.
Stay in the Know

The UPC Newsletter

Get expert insights and the top patent stories delivered straight to your inbox.